SUMO1P2

Across TCGA pan-cancer cohorts, SUMO1P2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated SUMO1P2 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher SUMO1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SUMO1P2 expression acts as an unfavorable survival marker, although some lineages such as LUSC and MESO show a favorable association.

COAD, LIHC, and LUSC are the cancer types where SUMO1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Quartile	All	0.679	0.845	.003	49	view →
LIHC	DFS	Tertile	All	0.233	0.457	<.001	42	view →
LUSC	OS	Tertile	III,IV	0.855	0.564	.006	38	view →
UCEC	DFS	Tertile	All	0.589	0.660	.028	24	view →
MESO	OS	Tertile	III,IV	1.000	0.319	.019	21	view →
THCA	DFS	Tertile	All	0.886	0.947	.004	21	view →
ACC	OS	Tertile	All	0.741	0.896	.022	15	view →
DLBC	DFS	Tertile	IV	0.120	0.827	.025	9	view →
PRAD	DFS	Tertile	All	0.882	0.942	.047	6	view →
OV	OS	Quartile	III,IV	0.373	0.291	.031	4	view →
PAAD	OS	Median	III,IV	0.629	1.000	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

SUMO1P2–COAD (OS)

Open the COAD breakdown →